Catalent May 13, 2026 Elpida Therapeutics, Catalent Partner for Late-Phase AAV Manufacturing - Contract Pharma
Catalent Apr 10, 2026 Cartherics deepens Catalent alliance to scale CAR-NK manufacturing - The Pharma Letter
Catalent Apr 1, 2026 Layoffs at Novo’s Ex-Catalent Site Despite Signs of Turnaround, Continued Investment - BioSpace
Catalent Apr 1, 2026 Catalent and GelMEDIX Enter Global Partnership for the Development and Clinical Manufacturing of iPSC-Derived Cell Therapies in Ocular and Retinal Diseases - BioInformant
Catalent Mar 10, 2026 Inspection issues remain at Catalent Indiana plant, pharma companies say - Inside INdiana Business
Catalent Feb 20, 2026 Catalent cuts staff by 96 in another round of layoffs in Maryland - Fierce Pharma
Catalent Jan 26, 2026 Catalent moves to wind down operations at EU cell therapy manufacturing hub - Fierce Pharma
Catalent Jan 12, 2026 SmartCella and Catalent Sign Nonexclusive License Agreement for GMP iPSCs - Business Wire
Catalent Nov 14, 2025 Catalent employee cites mismanagement as the firm cuts 77 more Maryland jobs - BioProcess International
Catalent Nov 6, 2025 Breaking: Catalent Confirms Additional Layoffs in Maryland as Gene Therapy Market Headwinds Persist - biobuzz.io
Catalent Oct 28, 2025 Catalent Unveils New Brand Amid Strategic Shift and Global Expansion - Contract Pharma
Catalent Jul 2, 2025 Gov. Evers, WEDC celebrate Catalent’s $45 Million expansion, adding to the state’s booming biohealth sector - WEDC